期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

自体造血干细胞移植能否作为非霍奇金淋巴瘤的一线治疗方案 被引量：5

If Autologous Stem-Cell Transplantation Can Be Front-Line Therapy of the Non-Hodgkin ’s Lymphoma
下载PDF
导出
摘要 淋巴瘤是一种起源于淋巴细胞的恶性增殖性疾病。近几年，淋巴瘤的发病率越来越高，并且呈现年轻化趋势。据世界卫生组织统计，淋巴瘤发病率的年增长率为7．5％，是目前发病率增长最快的恶性肿瘤之一，全球每年约有35万新发病例，死亡人数超过20万。我国淋巴瘤发病率为0．02％，每年新发病例2．5万人，死亡2万人，呈上升趋势。淋巴瘤的发病年龄以儿童和青壮年最为多见，是儿童最常见的恶性肿瘤之一。死于恶性淋巴瘤的患者平均年龄为49．9岁。低于所有恶性肿瘤平均死亡年龄的58．2岁。
作者 王黎 沈志祥
机构地区 上海交通大学附属瑞金医院血液科
出处 《循证医学》 CSCD 2008年第5期262-263,共2页 The Journal of Evidence-Based Medicine
关键词 自体干细胞移植 淋巴瘤 非霍奇金 一线治疗 autologous stem-cell transplantation lymphoma,non-Hodgkin front-line therapy
分类号 R733.1 [医药卫生—肿瘤]
  • 相关文献

参考文献6

  • 1Jemal A, Siegel R, Ward E, et al. Cancer Statistics, 2007 [J]. CA Cancer J Clin, 2007,57:43-66.
  • 2Shipp MA, Harrington DP, Anderson JR, et al. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project [J]. N Engl J Med, 1993,329:987-994.
  • 3Martelli M, Gherlinzoni F, De Renzo A, et al. Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: An Italian multicenter randomized trial [J]. J Clin Oncol, 2003,21(7):1255-1262.
  • 4Gisselbrecht C, Lepage E, Molina T, et al. Shortened firstline high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma [J]. J Clin Oncol, 2002,20(10):2472- 2479.
  • 5van Imhoff GW, van der Holt B, Mackenzie MA, et al. Impact of three courses of intensified CHOP prior to highdose sequential therapy followed by autologous stem-cell transplantation as first-line treatment in poor-risk, aggressive non-Hodgkin's lymphoma: Comparative analysis of Duch-Belgian hemato-oncology cooperative group studies 27 and 40 [J]. J Clin Oncol, 2005,23 (16) : 3793-3801.
  • 6Greb A, Bohlius J, Schiefer D, et al. High-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive non-Hodgkin lymphoma(NHL) in adults [DB/CD]. Cochrane Database Syst Rev, 2008,23 (1): CD004024.

同被引文献51

  • 1黄萨,提正太,李勇,李祎,张光.磁共振弥散加权成像鉴别脑脓肿和坏死囊变脑肿瘤[J].中国医学影像技术,2005,21(12):1815-1817. 被引量：5
  • 2王铁梅,于秋波.合理情绪疗法及其应用研究[J].佳木斯大学社会科学学报,2007,25(2):123-124. 被引量：33
  • 3Turner JJ,Hughes AM,Kricker A,et al.Use of the WHO lymphoma classification in a population-based epidemiological study.Ann Oncol,2004,15(4):631-637.
  • 4Babsky AM,Topper S,Zhang H,et al.Evaluation of extra-and intracellular apparent diffusion coefficient of sodium in rat skeletal muscle:effects of prolonged ischemia.Magn Reson Med,2008,59(3):485-491.
  • 5Mukherji SK,Chenevert TL,Castillo M.Diffusion-weighted magnetic resonance imaging.J Neuroophthalmol,2002,22(2):118-122.
  • 6Koh DM,Collins DJ.Diffusion-weighted MRI in the body:applications and challenges in oncology.AJR Am J Roentgenol,2007,188(6):1622-1635.
  • 7Chenevert TL,Stegman LD,Taylor JM,et al.Diffusion magnetic resonance imaging:an early surrogate marker of therapeutic efficacy in brain tumors.J Natl Cancer Inst,2000,92(24):2029-2036.
  • 8Gass A,Niendorf T,Hirsch JG.Acute and chronic changes of the apparent diffusion coefficient in neurological disorders-biophysical mechanisms and possible underlying histopathology.J Neurol Sci,2001,186(Suppl 1):S15-S23.
  • 9Humphries PD,Sebire NJ,Siegel MJ,et al.Tumors in pediatric patients at diffusion-weighted MR imaging:apparent diffusion coefficient and tumor cellularity.Radiology,2007,245(3):848-854.
  • 10Sadeghi N,D'Haene N,Decaestecker C,et al.Apparent diffusion coefficient and cerebral blood volume in brain gliomas:relation to tumor cell density and tumor microvessel density based on stereotactic biopsies.AJNR Am J Neuroradiol,2008,29(3):476-482.

引证文献5

二级引证文献50

循证医学
2008年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部